American Century Entities Disclose 4.2% Stake in Cable One (CABO)
Rhea-AI Filing Summary
American Century Investment Management, Inc., American Century Companies, Inc. and the Stowers Institute for Medical Research reported beneficial ownership of 237,107 shares of Cable One common stock, representing 4.2% of the class. The filers report sole voting power of 233,531 shares and sole dispositive power of 237,107, with no shared voting or dispositive power. The filing states these securities are held in the ordinary course of business and were not acquired to change or influence issuer control. It also notes ACIM is an investment adviser and a wholly owned subsidiary of ACC, and that no single client advised by ACIM owns more than 5% of the class.
Positive
- Transparent disclosure of aggregate beneficial ownership of 237,107 shares (4.2% of class).
- Clear allocation of voting and dispositive powers: 233,531 sole voting power and 237,107 sole dispositive power with no shared powers.
- Certification that holdings are held in the ordinary course of business and not to influence control.
- Organizational clarity provided: ACIM is an investment adviser and a wholly owned subsidiary of ACC, with Stowers identified as the control entity.
Negative
- None.
Insights
TL;DR: Reporting parties disclose a non-control, material stake of 4.2% in CABO with sole voting and dispositive power reported.
The Schedule 13G/A shows a clear, non-control ownership position: aggregate beneficial ownership of 237,107 shares representing 4.2% of Cable One's common stock. Voting and dispositive power are reported as primarily sole, which clarifies who can direct voting and dispositions. The filing also affirms holdings are in the ordinary course and not intended to influence control, which is consistent with a passive investor posture under Rule 13d-1(b). For investors, this disclosure increases transparency about sizable institutional positions without indicating activist intent.
TL;DR: Ownership and control lines are delineated; the filing signals transparency but no governance change.
The document identifies the reporting entities and their relationships: ACIM as an investment adviser and a subsidiary of ACC, controlled by Stowers Institute for Medical Research. The allocation of sole voting power (233,531 shares) versus sole dispositive power (237,107 shares) and zero shared powers provides useful detail on who legally can vote and sell the securities. The certification that the position was not acquired to influence control supports a passive classification, reducing immediate governance implications. This is informative for board and governance monitoring but not indicative of a coordinated control effort.